Press Releases
Keyword Search
March 27, 2020
Ocugen Provides Business Update and Full Year 2019 Financial Results
Additional Formats
March 20, 2020
Ocugen to Host Conference Call on Friday, March 27 at 8:30 a.m. ET to Discuss 2019 Financial Results and Provide Business Update
Additional Formats
March 3, 2020
Nature Gene Therapy Publishes Preclinical Data of Ocugen’s OCU400 (NR2E3-AAV) Genetic Modifier to treat Retinitis Pigmentosa (RP)
Additional Formats
February 10, 2020
Ocugen to Present at NobleCon16 - Noble Capital Markets’ Sixteenth Annual Investor Conference
Additional Formats
